Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218)... Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, February 15, 2016

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218)...



open access 
 Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
......Patients with ovarian cancer represent a unique group of cancer patients, because they are treated with a combination of both extensive surgery and intensive combination chemotherapy. They therefore represent an important population to study with respect to avoiding unnecessary readmission. In order to strategize how to decrease readmissions and improve patient quality of care, it is imperative to first identify predictors of readmission. To date, most studies related to unplanned readmission of patients with advanced ovarian cancer have been limited to single institution studies with retrospective capture of data.....

Table 1 Characteristics of re-hospitalized patients.

Table 2 Hospitalized patients: medical history and surgical details.

Table 3 Rehospitalization toxicities. 

 Fifty-nine patients had 2 or more readmissions (Tables 4 and and 5).

read full text - open access


0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.